Moleculin Biotech Inc [NASDAQ: MBRX] jumped around 0.02 points on Tuesday, while shares priced at $0.41 at the close of the session, up 4.63%.
Moleculin Biotech Inc stock is now -83.65% down from its year-to-date (YTD) trading value. MBRX Stock saw the intraday high of $0.423 and lowest of $0.39 per share. The company’s 52-week high price is 3.65, which means current price is +62.80% above from all time high which was touched on 02/13/25.
Compared to the average trading volume of 6.35M shares, MBRX reached a trading volume of 6013997 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Moleculin Biotech Inc [MBRX]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MBRX shares is $6.67 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MBRX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Moleculin Biotech Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 09, 2025. The new note on the price target was released on February 12, 2025, representing the official price target for Moleculin Biotech Inc stock. Previously, the target price had yet another raise to $14, while Oppenheimer analysts kept a Outperform rating on MBRX stock.
How has MBRX stock performed recently?
Moleculin Biotech Inc [MBRX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 7.39. With this latest performance, MBRX shares dropped by -39.66% in over the last four-week period, additionally sinking by -64.61% over the last 6 months – not to mention a drop of -76.06% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MBRX stock in for the last two-week period is set at 37.49, with the RSI for the last a single of trading hit 0.0532, and the three-weeks RSI is set at 0.0672 for Moleculin Biotech Inc [MBRX]. The present Moving Average for the last 50 days of trading for this stock 0.5718, while it was recorded at 0.3851 for the last single week of trading, and 1.1322 for the last 200 days.
Moleculin Biotech Inc (MBRX) Capital Structure & Debt Analysis
Moleculin Biotech Inc (MBRX) Efficiency & Liquidity Metrics
Moleculin Biotech Inc (MBRX) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Moleculin Biotech Inc. (MBRX) effectively leverages its workforce, generating an average of -$1561764.71 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.15% and a Quick Ratio of 1.15%, indicating strong ability to cover short-term liabilities.
Earnings analysis for Moleculin Biotech Inc [MBRX]
With the latest financial reports released by the company, Moleculin Biotech Inc posted -2.85/share EPS, while the average EPS was predicted by analysts to be reported at -2.44/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.41. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MBRX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Moleculin Biotech Inc go to 45.64%.
Insider trade positions for Moleculin Biotech Inc [MBRX]
There are presently around $6.67%, or 6.91%% of MBRX stock, in the hands of institutional investors. The top three institutional holders of MBRX stocks are: ARMISTICE CAPITAL, LLC with ownership of 0.16 million shares, which is approximately 6.1339%. VANGUARD GROUP INC, holding 84418.0 shares of the stock with an approximate value of $$0.3 million in MBRX stocks shares; and VANGUARD GROUP INC, currently with $$0.12 million in MBRX stock with ownership which is approximately 1.3272%.
